| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.MCE.2009.12.027 |
| P698 | PubMed publication ID | 20036710 |
| P50 | author | Juliana Chung-ngor Chan | Q40358533 |
| P2093 | author name string | Hong-Xi Xu | |
| Li-Zhong Liu | |||
| Peter C Y Tong | |||
| Stanley C K Cheung | |||
| Lin-Lin Lan | |||
| Stanley K S Ho | |||
| P433 | issue | 1-2 | |
| P921 | main subject | insulin resistance | Q1053470 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 148-153 | |
| P577 | publication date | 2009-12-29 | |
| P1433 | published in | Molecular and Cellular Endocrinology | Q1573600 |
| P1476 | title | Berberine modulates insulin signaling transduction in insulin-resistant cells | |
| P478 | volume | 317 |
| Q33689169 | AMPK activation--protean potential for boosting healthspan |
| Q42140741 | Antihyperglycemic and Antihyperlipidemic Effects of Fruit Aqueous Extract of Berberis integerrima Bge. in Streptozotocin-induced Diabetic Rats |
| Q39547455 | Berberine acutely activates the glucose transport activity of GLUT1 |
| Q38965186 | Berberine and Its Role in Chronic Disease |
| Q38421650 | Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase |
| Q64084960 | Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics |
| Q64885881 | Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation. |
| Q51369549 | Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver |
| Q39108328 | Capsaicin stimulates glucose uptake in C2C12 muscle cells via the reactive oxygen species (ROS)/AMPK/p38 MAPK pathway |
| Q55274553 | Cellular stress response mechanisms of Rhizoma coptidis: a systematic review. |
| Q64064784 | Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology |
| Q90669218 | Guava Leaf Extract Attenuates Insulin Resistance via the PI3K/Akt Signaling Pathway in a Type 2 Diabetic Mouse Model |
| Q38712159 | Multiple AMPK activators inhibit l-carnitine uptake in C2C12 skeletal muscle myotubes |
| Q42516112 | Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes |
| Q35138347 | Potential benefits of berberine in the management of perimenopausal syndrome. |
| Q84529745 | Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine |
| Q28384697 | Protection of Gastrointestinal Mucosa from Acute Heavy Alcohol Consumption: The Effect of Berberine and Its Correlation with TLR2, 4/IL1β-TNFα Signaling |
| Q37227111 | Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis |
| Q33748376 | Spatholobus suberectus Exhibits Antidiabetic Activity In Vitro and In Vivo through Activation of AKT-AMPK Pathway |
| Q39369328 | Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice |
| Q42001221 | The Chinese herbal medicine FTZ attenuates insulin resistance via IRS1 and PI3K in vitro and in rats with metabolic syndrome |
| Q26851917 | The antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological research |
| Q37847181 | Treatment of non-alcoholic fatty liver disease with focus on emerging drugs |
Search more.